Rotavirus vaccines: how they work or don't work (Q37081817)

18 August 2017

1 reference

title

Rotavirus vaccines: how they work or don't work (English)

1 reference

18 August 2017

1 reference

Richard L Ward

1

1 reference

18 August 2017

publication date

12 February 2008

1 reference

Expert Reviews in Molecular Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

10

1 reference

18 August 2017

page(s)

e5

1 reference

Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Serum IgG mediates mucosal immunity against rotavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Structure of the intestinal flora responsible for development of the gut immune system in a rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Seroepidemiologic Evaluation of Antibodies to Rotavirus as Correlates of the Risk of Clinically Significant Rotavirus Diarrhea in Rural Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Protection from Rotavirus Reinfection: 2-Year Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Pathogenesis of rotavirus-induced diarrhea. Preliminary studies in miniature swine piglet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Human rotavirus enteritis induced in conventional piglets. Intestinal structure and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Three-dimensional visualization of the rotavirus hemagglutinin structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Rotavirus and severe childhood diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Serum antibody as a marker of protection against natural rotavirus infection and disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988-1999

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Fecal antibody responses to symptomatic and asymptomatic rotavirus infections

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Influences of microbiota on intestinal immune system development

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000574

7 January 2021

10.1017/S1462399408000574

Identifiers

DOI

1 reference

18 August 2017

1 reference